Clinical Trial Update: Metoprolol XR in Heart Failure With Normal Ejection Fraction [Phase 2]

View source ↗

Summary

Phase 2 trial update on Metoprolol XR for heart failure with preserved ejection fraction (diastolic heart failure).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diastolic Heart Failure
• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Metoprolol XR (metoprolol succinate extended-release)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Diastolic Heart Failure | Phase 2 | Status: COMPLETED